The findings of our study indicate that severe COVID-19 patients have higher INR (coagulation biomarker), creatinine (renal injury biomarker), CRP and PCT (inflammation biomarkers), and fibrinogen (coagulation biomarker) compared to the moderate group. Here, CRP is linked to COVID-19.